SOD1 and Parkinson disease: These studies showed decreased antioxidant capacity in PD model groups, which could be significantly mitigated by BCP, TCH, or RSV administration [43,46,47,48,50,51,54], except for the study of Anandhan et al. (2010) [54] that reported elevated SOD and CAT activities in their PD model.